Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients
SARS-CoV-2 vaccinations are not free from side effects. Usually, they are mild or moderate but occasionally severe. One of these severe side effects is Guillain-Barré syndrome (GBS). This review summarizes and discusses GBS as a side effect of SARS-CoV-2 vaccinations (SCoVaG) based on recent researc...
Main Authors: | Josef Finsterer, Fulvio A. Scorza, Carla A. Scorza |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2021-10-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100428&tlng=en |
Similar Items
-
Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2021-01-01) -
SARS‐CoV‐2‐related polyradiculitis must be preceded by PCR‐confirmed COVID‐19
by: Josef Finsterer
Published: (2023-04-01) -
Guillain-Barré Syndrome Associated with COVID-19 Vaccination
by: Josef Finsterer, et al.
Published: (2022-05-01) -
Guillain-Barre syndrome in 220 patients with COVID-19
by: Josef Finsterer, et al.
Published: (2021-05-01) -
Triggers of Guillain–Barré Syndrome: <i>Campylobacter jejuni</i> Predominates
by: Josef Finsterer
Published: (2022-11-01)